Kevin J. Cameron

Kevin J. Cameron is a declared insider at 2 companies; the most frequent names are Keryx Biopharmaceuticals Inc and Reddy Ice Holdings Inc. We count 18 filings; the first trade dates from 14 November 2008 and the latest from 12 December 2018.

Every open-market trade on record is a sale: 2 sales worth €15k. Besides market trades, the filings include 14 share grants and 1 option exercise. Since January 2018: no purchases and 2 sales on the market.

The latest filing, published on 13 December 2018, reports a transaction in Keryx Biopharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.